Mostrando 9 resultados de: 9
Filtros aplicados
Publisher
Annals of Hepatology(2)
Clinical Liver Disease(2)
Clinical Gastroenterology and Hepatology(1)
Hepatology(1)
Magnetic Resonance Imaging(1)
Área temáticas
Enfermedades(4)
Problemas sociales y servicios a grupos(4)
Medicina y salud(3)
Farmacología y terapéutica(2)
Medicina forense; incidencia de enfermedades(2)
Changing epidemiology of hepatocellular carcinoma in South America: A report from the South American liver research network
ArticleAbstract: Introduction and objectives: Most epidemiological data on hepatocellular carcinoma (HCC) originate fPalabras claves:Hispanics, Liver cirrhosis, NAFLDAutores:Anugwom C., Arrese M., Baca E.L., Balderramo D., Debes J.D., Enrique Carrera, Farah M., Ferrer J.D., Mattos A.Z., Possebon J.P.P., Prieto J.E.Fuentes:scopusCuando la creación de un consorcio proporciona respuestas útiles: experiencia de la Latin American DILI network (LATINDILIN)
ArticleAbstract:Palabras claves:Autores:Andrade R.J., Arrese M., Bessone F., Brahm J., Contreras F., Enrique Carrera, Girala M., Hernández N., Isabel Lucena M., Lizarzabal M.I., Medina-Cáliz I., Mendez-Sanchez N., Mendizábal M., Nunes V., Paraná R., Parra-Martínez C., Sanchez A., Santos G., Sanz-Villanueva L., Tagle M.Fuentes:scopusAdvancing the global public health agenda for NAFLD: a consensus statement
ReviewAbstract: Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects approxPalabras claves:Autores:Åberg F., Adams L., Allen A.M., Alnaser F., Alqahtani S.A., Alswat K., Alvaro D., Andrade R.J., Anstee Q.M., Arab J.P., Arrese M., Awuku Y.A., Ayesha M., Baatarkhuu O., Bakieva S., Basu R., Bataller R., Batterham R.L., Bedri S., Bosi E., Bourliere M., Bruha R., Bugianesi E., Burra P., Buti M., Byrne C.D., Calleja J.L., Carrieri P., Carter F., Castera L., Castro-Narro G.E., Chan H.L.Y., Chan W.K., Chang Y., Colombo M., Coppell K.J., Corey K., Cortez-Pinto H., Craxi A., Crespo J., Cryer D., Cusi K., Dassanayake A., de Ledinghen V., DelPrato S., Demaio A., Desalegn H., Dillon J., Dirac M.A., Dorairaj P., Duseja A., Ekstedt M., El Kassas M., Elsanousi O.M., Esmat G., Fan J.G., Farpour-Lambert N., Fernandez M.I.C., Flisiak R., Fouad Y., Francque S., Fuchs M., Gabriela Castillo-López, Gani R.A., George J., Gerber L., Ghazinyan H., Gheorghe L., Goh G.B.B., Grønbæk H., Gulnara A., Hagström H., Hamid S., Hebditch V., Huang T.T.K., Ismail M.H., Juan José Suárez, Kautz A., Khatry M.S.A., Lazarus J.V., Loomba R., Mark H.E., Martins A.d.A.S., Miller V., Murillo O.A., Naamani K.A., Newsome P.N., Ninburg M., Ocama P., PATRICIO LOPEZ -JARAMILLO, Ratziu V., Rinella M., Romero D., Romero‐Gomez M., Sarin S.K., Schattenberg J.M., Tsochatzis E.A., Valenti L., Wong V.W.S., Yilmaz Y., Younossi Z.M., Zelber-Sagi S.Fuentes:scopusHerbal and Dietary Supplements-Induced Liver Injury in Latin America: Experience From the LATINDILI Network
ArticleAbstract: Background: Herbal and dietary supplements (HDS) consumption, a growing cause of hepatotoxicity, isPalabras claves:Drug-Induced Liver Injury, Hepatotoxicity, Herbal and Dietary Supplements, Herbal-Induced Liver Injury, Latin America, LATINDILI Network, Liver toxicityAutores:Alvarez-Alvarez I., Anders M., Andrade R.J., Arrese M., Bessone F., Caballano-Infantes E., Cabello M.R., Chiodi D., Enrique Carrera, García-Cortés M., Hernández N., Lizarzabal M.I., Lucena M.I., Medina-Cáliz I., Mendizábal M., Montes P., Niu H., Nunes V., Paraná R., Peralta M., Pinazo J., Ridruejo E., Santos G., Schinoni M.I., Tagle M.Fuentes:scopusIntrahepatic portal vein blood volume estimated by non-contrast magnetic resonance imaging for the assessment of portal hypertension
ArticleAbstract: Purpose: To investigate the feasibility of estimating the portal vein blood volume that flows into tPalabras claves:Arterial spin labeling, Cirrhosis, Intrahepatic portal vein, Non-contrast MRI, Portal hypertensionAutores:Uribe, S., Andia M.E., Arab J.P., Arrese M., C. Tejos, D. Aguirre Reyes, Daniel Fernando Aguirre-Reyes, Irarrazaval P., J. Arab, J. Sotelo, M Andia, M. Arrese, P. Irarrázaval, R. Tejos, Sotelo J.A., Tejos C., Tejos R., Uribe S.A.Fuentes:rraaescopusImpact of Public Health Policies on Alcohol-Associated Liver Disease in Latin America: An Ecological Multinational Study
ArticleAbstract: Background and Aims: Alcohol-associated liver disease (ALD) is the leading cause of liver-related moPalabras claves:Autores:Arab J.P., Araujo R.C., Arrese M., Bataller R., Brahmania M., Corsi O., Díaz L.A., Ferreccio C., Fuentes-López E., Galo F. Pazmiño, Hernández N., Idalsoaga F., Lazo M., Márquez-Lomas A., Mendizábal M., Montes P., Ramírez C.A., Roblero J.P., Singal A.K., Tijera F.d.l., Toro L.G.Fuentes:scopusWhen the Creation of a Consortium Provides Useful Answers: Experience of The Latin American DILI Network (LATINDILIN)
ReviewAbstract:Palabras claves:Autores:Andrade R.J., Arrese M., Bessone F., Brahm J., Contreras F., Enrique Carrera, Girala M., Hernández N., Isabel Lucena M., Lizarzabal M.I., Medina-Cáliz I., Mendez-Sanchez N., Mendizábal M., Nunes V., Paraná R., Parra-Martínez C., Sanchez A., Santos G., Sanz-Villanueva L., Tagle M.Fuentes:scopusThe establishment of public health policies and the burden of non-alcoholic fatty liver disease in the Americas
ReviewAbstract: Non-alcoholic fatty liver disease (NAFLD) affects 20–25% of the general population and is associatedPalabras claves:Autores:Arab J.P., Arnold J., Arrese M., Ayares G., Barrera F., Bataller R., Brahmania M., Castellanos-Fernández M., Chavez-Tapia N., Chery O., Díaz L.A., Dirchwolf M., Elizondo M., Enrique Carrera, Ferreccio C., Fuentes-López E., Girala M., Guerra P., Idalsoaga F., Kamath P.S., Lacalle L., Lazarus J.V., Lazo M., Lombardo J., Márquez-Lomas A., Medel M.P., Mendez-Sanchez N., Oliveira C.P., Padilla M., Ramírez C.A., Restrepo J.C., Roblero J.P., Sánchez A., Sánchez M., Singal A.K., Tagle M., Viñuela F.Fuentes:scopusAssessment of hepatic fatty acids during non-alcoholic steatohepatitis progression using magnetic resonance spectroscopy
ArticleAbstract: Introduction and objectives: Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum of livPalabras claves:Choline-deficient, l-amino acid-defined (CDAA), Gas chromatography with mass spectrometry (GC–MS), Magnetic resonance spectroscopy, Mouse model, Non-alcoholic fatty liver disease (NAFLD), SteatohepatitisAutores:Andia M.E., Arrese M., Botnar R., Cabrera D., Eykyn T.R., Fabián Mauricio Santana Romo, Fabián Santana-Romo, Lavin B., Oyarzún J.E., Phinikaridou A., Uribe S.A., Xavier A., Zacconi F.C.Fuentes:googlescopus